allergic rhinitis. Other allergic rhinitis
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, 20 mg of triamcinolone will be given intraoperatively in each lower nasal concha. Intervention 2: Control group: No drugs will be used.
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Major entry into the study includes all patients undergoing rhinoplasty due to allergic rhinitis in year 96-97.
Exclusion criteria
Exclusion criteria: Major exclusion criteria include a history of respiratory infections in the past 1 month, systemic illness, alcohol consumption, pregnancy or lactation, corticosteroid therapy, mental disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of symptoms and quality of life. Timepoint: Complete the questionnaires before and one month after the injection. Method of measurement: Standard questionnaire of symptoms and quality of life in patients with rhinoconjunctivitis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of symptoms and quality of life. Timepoint: Complete the questionnaires before and one month after the injection. Method of measurement: Standard questionnaire of symptoms and quality of life in patients with rhinoconjunctivitis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Gholamali Dashti
Zahedan University of Medical Sciences
Outcome results
None listed